Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 668

1.

Giardiasis: a pharmacotherapy review.

Escobedo AA, Cimerman S.

Expert Opin Pharmacother. 2007 Aug;8(12):1885-902. Review.

PMID:
17696791
2.

Review article: the management of Giardiasis.

Vesy CJ, Peterson WL.

Aliment Pharmacol Ther. 1999 Jul;13(7):843-50. Review.

3.

Efficacy of antigiardial drugs.

Wright JM, Dunn LA, Upcroft P, Upcroft JA.

Expert Opin Drug Saf. 2003 Nov;2(6):529-41. Review.

PMID:
14585063
4.

Antigiardial drugs.

Harris JC, Plummer S, Lloyd D.

Appl Microbiol Biotechnol. 2001 Dec;57(5-6):614-9. Review.

PMID:
11778868
5.

Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives.

Lalle M.

Infect Disord Drug Targets. 2010 Aug;10(4):283-94. Review.

PMID:
20429863
6.

[Intestinal giardiasis. Mini-review].

Rivera M, de la Parte MA, Hurtado P, Magaldi L, Collazo M.

Invest Clin. 2002 Jun;43(2):119-28. Review. Spanish.

PMID:
12108026
7.

Treatment of patients with refractory giardiasis.

Nash TE, Ohl CA, Thomas E, Subramanian G, Keiser P, Moore TA.

Clin Infect Dis. 2001 Jul 1;33(1):22-8. Epub 2001 May 23.

8.

Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France.

Lemée V, Zaharia I, Nevez G, Rabodonirina M, Brasseur P, Ballet JJ, Favennec L.

J Antimicrob Chemother. 2000 Nov;46(5):819-21.

9.

Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome.

Abboud P, Lemée V, Gargala G, Brasseur P, Ballet JJ, Borsa-Lebas F, Caron F, Favennec L.

Clin Infect Dis. 2001 Jun 15;32(12):1792-4. Epub 2001 May 9.

10.

Synthesis and electrochemistry of 2-ethenyl and 2-ethanyl derivatives of 5-nitroimidazole and antimicrobial activity against Giardia lamblia.

Valdez CA, Tripp JC, Miyamoto Y, Kalisiak J, Hruz P, Andersen YS, Brown SE, Kangas K, Arzu LV, Davids BJ, Gillin FD, Upcroft JA, Upcroft P, Fokin VV, Smith DK, Sharpless KB, Eckmann L.

J Med Chem. 2009 Jul 9;52(13):4038-53. doi: 10.1021/jm900356n.

11.

Synovitis secondary to giardiasis in children.

Letts M, Davidson D, Lalonde F.

Am J Orthop (Belle Mead NJ). 1998 Jun;27(6):451-4. Review.

PMID:
9652890
12.

Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey.

Yereli K, Balcioğlu IC, Ertan P, Limoncu E, Onağ A.

Clin Microbiol Infect. 2004 Jun;10(6):527-9.

13.

A comparative clinical trial of albendazole versus metronidazole in giardiasis.

Misra PK, Kumar A, Agarwal V, Jagota SC.

Indian Pediatr. 1995 Mar;32(3):291-4. Corrected and republished in: Indian Pediatr. 1995 Jul;32(7):779-82.

PMID:
8613282
14.

Cryptosporidium and Giardia: treatment options and prospects for new drugs.

Rossignol JF.

Exp Parasitol. 2010 Jan;124(1):45-53. doi: 10.1016/j.exppara.2009.07.005. Epub 2009 Jul 24.

PMID:
19632225
15.

Characterization of a Giardia lamblia WB C6 clone resistant to the isoflavone formononetin.

Sterk M, Müller J, Hemphill A, Müller N.

Microbiology. 2007 Dec;153(Pt 12):4150-8.

PMID:
18048928
16.

Unusual presentations of Giardia lamblia; a report of four cases.

Obidike EO, Igbodo C.

Niger J Clin Pract. 2010 Jun;13(2):225-7.

17.

Giardiasis: recent progress in chemotherapy and drug development.

Minenoa T, Avery MA.

Curr Pharm Des. 2003;9(11):841-55. Review.

PMID:
12678869
18.

A comparative clinical trial of albendazole versus metronidazole in children with giardiasis.

Misra PK, Kumar A, Agarwal V, Jagota SC.

Indian Pediatr. 1995 Jul;32(7):779-82.

PMID:
8617554
19.

Metronidazole for the treatment of feline giardiasis.

Scorza AV, Lappin MR.

J Feline Med Surg. 2004 Jun;6(3):157-60.

PMID:
15135352
20.

Evaluation of silymarin in the treatment on asymptomatic Giardia infections in dogs.

Chon SK, Kim NS.

Parasitol Res. 2005 Dec;97(6):445-51. Epub 2005 Sep 9.

PMID:
16151741
Items per page

Supplemental Content

Write to the Help Desk